TriSalus Life Sciences In...
(TLSI)
undefined
undefined%
At close: undefined
5.02
-0.99%
After-hours Jan 03, 2025, 04:00 PM EST
Company Description
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors.
The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors.
It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers.
The company is based in Westminster, Colorado.
TriSalus Life Sciences Inc.
| Country | United States |
| IPO Date | Feb 8, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 107 |
| CEO | Mary T. Szela B.S.N., M.B.A. |
Contact Details
Address: 6272 West 91st Avenue Westminster, Colorado United States | |
| Website | https://trisaluslifesci.com |
Stock Details
| Ticker Symbol | TLSI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001826667 |
| CUSIP Number | 89680M101 |
| ISIN Number | US89680M1018 |
| Employer ID | 85-3009869 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Mary T. Szela B.S.N., M.B.A. | Chief Executive Officer, President & Director |
| Sean Edward Murphy | Chief Financial Officer & Director |
| Dr. Bryan F. Cox Ph.D. | Chief Scientific & Manufacturing Officer |
| Dr. Richard B. Marshak M.B.A., MBA, VMD | Senior Vice President of Corporate Development & Strategy |
| James E. Young | Senior Vice President of Investor Relations & Treasurer |
| Jennifer L. Stevens J.D. | Chief Regulatory Officer |
| Jodi Devlin | President of Commercial Operations |
| Lori Ann Santamaria | Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 30, 2024 | D | Filing |
| Dec 19, 2024 | 4 | Filing |
| Dec 19, 2024 | 4 | Filing |
| Dec 19, 2024 | 4 | Filing |
| Dec 19, 2024 | SCHEDULE 13D/A | [Amend] Filing |
| Dec 19, 2024 | SCHEDULE 13D/A | [Amend] Filing |
| Dec 12, 2024 | 4 | Filing |
| Dec 04, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 25, 2024 | 4 | Filing |
| Nov 22, 2024 | 4 | Filing |